top of page
Search


New evidence reveals the power of biologics to improve severe asthma outcomes in patients with T2 comorbidities
ISAR ’s new publication "Association between T2-related co-morbidities and effectiveness of biologics in severe asthma” to the highly...
Mar 15, 20241 min read


Latest ISAR research reveals the significant impact of pre-existing health on response to treatment with biologics in Severe Asthma
Important progress has been gained in the journey towards understanding response to biologic therapy in severe asthma through the...
Feb 23, 20242 min read


Biologics dramatically reduce steroid requirements and exacerbation rates in severe asthma patients
The International Severe Asthma Registry (ISAR)’s newest study has found that keeping severe asthma patients on high oral corticosteroid...
Jul 25, 20231 min read
bottom of page